vs
LifeStance Health Group, Inc.（LFST）与STEPAN CO（SCL）财务数据对比。点击上方公司名可切换其他公司
STEPAN CO的季度营收约是LifeStance Health Group, Inc.的1.6倍（$604.5M vs $382.2M），STEPAN CO净利率更高（3.3% vs 3.1%，领先0.2%），LifeStance Health Group, Inc.同比增速更快（17.4% vs 1.9%），过去两年LifeStance Health Group, Inc.的营收复合增速更高（12.8% vs 4.2%）
LifeStance Health Group是美国的门诊行为健康服务提供商，支持线下面诊与远程诊疗两种服务模式，业务涵盖心理咨询、精神科诊疗、经颅磁刺激（TMS）以及氯胺酮治疗等。该公司曾多次因劳动违规、客户信息泄露及误导投资者相关问题遭遇诉讼。
斯特潘公司是一家美国特种化学品制造商，总部位于伊利诺伊州诺斯布鲁克，1932年由小阿尔弗雷德·C·斯特潘创立，现有约2000名员工，目前由创始人的孙子小F·奎因·斯特潘执掌。该公司是全球最大的阴离子表面活性剂商品生产商，产品用于提升洗涤剂、洗发水、牙膏及化妆品的起泡与清洁能力。
LFST vs SCL — 直观对比
营收规模更大
SCL
是对方的1.6倍
$382.2M
营收增速更快
LFST
高出15.5%
1.9%
净利率更高
SCL
高出0.2%
3.1%
两年增速更快
LFST
近两年复合增速
4.2%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $382.2M | $604.5M |
| 净利润 | $11.7M | $19.7M |
| 毛利率 | — | 10.7% |
| 营业利润率 | 4.7% | 4.7% |
| 净利率 | 3.1% | 3.3% |
| 营收同比 | 17.4% | 1.9% |
| 净利润同比 | 264.1% | — |
| 每股收益（稀释后） | — | $0.86 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LFSTSCL
| Q1 26 | — | $604.5M | ||
| Q4 25 | $382.2M | $553.9M | ||
| Q3 25 | $363.8M | $590.3M | ||
| Q2 25 | $345.3M | $594.7M | ||
| Q1 25 | $333.0M | $593.3M | ||
| Q4 24 | $325.5M | $525.6M | ||
| Q3 24 | $312.7M | $546.8M | ||
| Q2 24 | $312.3M | $556.4M |
净利润LFSTSCL
| Q1 26 | — | $19.7M | ||
| Q4 25 | $11.7M | $5.0M | ||
| Q3 25 | $1.1M | $10.8M | ||
| Q2 25 | $-3.8M | $11.3M | ||
| Q1 25 | $709.0K | $19.7M | ||
| Q4 24 | $-7.1M | $3.4M | ||
| Q3 24 | $-6.0M | $23.6M | ||
| Q2 24 | $-23.3M | $9.5M |
毛利率LFSTSCL
| Q1 26 | — | 10.7% | ||
| Q4 25 | — | 9.3% | ||
| Q3 25 | — | 12.0% | ||
| Q2 25 | — | 12.1% | ||
| Q1 25 | — | 12.7% | ||
| Q4 24 | — | 10.8% | ||
| Q3 24 | — | 13.8% | ||
| Q2 24 | — | 12.5% |
营业利润率LFSTSCL
| Q1 26 | — | 4.7% | ||
| Q4 25 | 4.7% | 1.9% | ||
| Q3 25 | 2.0% | 3.7% | ||
| Q2 25 | -0.9% | 3.0% | ||
| Q1 25 | 0.5% | 4.8% | ||
| Q4 24 | 0.3% | 1.5% | ||
| Q3 24 | 0.0% | 4.4% | ||
| Q2 24 | -5.1% | 3.4% |
净利率LFSTSCL
| Q1 26 | — | 3.3% | ||
| Q4 25 | 3.1% | 0.9% | ||
| Q3 25 | 0.3% | 1.8% | ||
| Q2 25 | -1.1% | 1.9% | ||
| Q1 25 | 0.2% | 3.3% | ||
| Q4 24 | -2.2% | 0.6% | ||
| Q3 24 | -1.9% | 4.3% | ||
| Q2 24 | -7.5% | 1.7% |
每股收益（稀释后）LFSTSCL
| Q1 26 | — | $0.86 | ||
| Q4 25 | — | $0.22 | ||
| Q3 25 | — | $0.47 | ||
| Q2 25 | — | $0.50 | ||
| Q1 25 | — | $0.86 | ||
| Q4 24 | — | $0.14 | ||
| Q3 24 | — | $1.03 | ||
| Q2 24 | — | $0.42 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $248.6M | — |
| 总债务越低越好 | $282.8M | $328.4M |
| 股东权益账面价值 | $1.5B | $1.2B |
| 总资产 | $2.2B | $2.3B |
| 负债/权益比越低杠杆越低 | 0.19× | 0.28× |
8季度趋势，按日历期对齐
现金及短期投资LFSTSCL
| Q1 26 | — | — | ||
| Q4 25 | $248.6M | $132.7M | ||
| Q3 25 | $203.9M | $118.5M | ||
| Q2 25 | $188.9M | $88.9M | ||
| Q1 25 | $134.3M | $107.5M | ||
| Q4 24 | $154.6M | $99.7M | ||
| Q3 24 | $102.6M | $147.3M | ||
| Q2 24 | $87.0M | $124.7M |
总债务LFSTSCL
| Q1 26 | — | $328.4M | ||
| Q4 25 | $282.8M | $626.7M | ||
| Q3 25 | $284.6M | $655.5M | ||
| Q2 25 | $286.4M | $658.0M | ||
| Q1 25 | $288.2M | $659.3M | ||
| Q4 24 | $290.0M | $625.4M | ||
| Q3 24 | $287.3M | $688.5M | ||
| Q2 24 | $288.0M | $657.1M |
股东权益LFSTSCL
| Q1 26 | — | $1.2B | ||
| Q4 25 | $1.5B | $1.2B | ||
| Q3 25 | $1.5B | $1.2B | ||
| Q2 25 | $1.5B | $1.2B | ||
| Q1 25 | $1.5B | $1.2B | ||
| Q4 24 | $1.4B | $1.2B | ||
| Q3 24 | $1.4B | $1.2B | ||
| Q2 24 | $1.4B | $1.2B |
总资产LFSTSCL
| Q1 26 | — | $2.3B | ||
| Q4 25 | $2.2B | $2.4B | ||
| Q3 25 | $2.1B | $2.4B | ||
| Q2 25 | $2.1B | $2.4B | ||
| Q1 25 | $2.1B | $2.4B | ||
| Q4 24 | $2.1B | $2.3B | ||
| Q3 24 | $2.1B | $2.4B | ||
| Q2 24 | $2.1B | $2.3B |
负债/权益比LFSTSCL
| Q1 26 | — | 0.28× | ||
| Q4 25 | 0.19× | 0.50× | ||
| Q3 25 | 0.19× | 0.53× | ||
| Q2 25 | 0.19× | 0.53× | ||
| Q1 25 | 0.20× | 0.55× | ||
| Q4 24 | 0.20× | 0.53× | ||
| Q3 24 | 0.20× | 0.56× | ||
| Q2 24 | 0.20× | 0.55× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $57.6M | — |
| 自由现金流经营现金流 - 资本支出 | $46.6M | — |
| 自由现金流率自由现金流/营收 | 12.2% | — |
| 资本支出强度资本支出/营收 | 2.9% | — |
| 现金转化率经营现金流/净利润 | 4.93× | — |
| 过去12个月自由现金流最近4个季度 | $110.0M | — |
8季度趋势，按日历期对齐
经营现金流LFSTSCL
| Q1 26 | — | — | ||
| Q4 25 | $57.6M | $60.0M | ||
| Q3 25 | $27.3M | $69.8M | ||
| Q2 25 | $64.4M | $11.2M | ||
| Q1 25 | $-3.1M | $6.9M | ||
| Q4 24 | $62.3M | $68.3M | ||
| Q3 24 | $22.7M | $22.7M | ||
| Q2 24 | $44.1M | $29.5M |
自由现金流LFSTSCL
| Q1 26 | — | — | ||
| Q4 25 | $46.6M | $25.4M | ||
| Q3 25 | $17.0M | $40.2M | ||
| Q2 25 | $56.6M | $-14.4M | ||
| Q1 25 | $-10.3M | $-25.8M | ||
| Q4 24 | $56.0M | $32.1M | ||
| Q3 24 | $17.7M | $-4.0M | ||
| Q2 24 | $39.0M | $-208.0K |
自由现金流率LFSTSCL
| Q1 26 | — | — | ||
| Q4 25 | 12.2% | 4.6% | ||
| Q3 25 | 4.7% | 6.8% | ||
| Q2 25 | 16.4% | -2.4% | ||
| Q1 25 | -3.1% | -4.3% | ||
| Q4 24 | 17.2% | 6.1% | ||
| Q3 24 | 5.7% | -0.7% | ||
| Q2 24 | 12.5% | -0.0% |
资本支出强度LFSTSCL
| Q1 26 | — | — | ||
| Q4 25 | 2.9% | 6.3% | ||
| Q3 25 | 2.8% | 5.0% | ||
| Q2 25 | 2.2% | 4.3% | ||
| Q1 25 | 2.2% | 5.5% | ||
| Q4 24 | 1.9% | 6.9% | ||
| Q3 24 | 1.6% | 4.9% | ||
| Q2 24 | 1.6% | 5.3% |
现金转化率LFSTSCL
| Q1 26 | — | — | ||
| Q4 25 | 4.93× | 11.99× | ||
| Q3 25 | 25.34× | 6.44× | ||
| Q2 25 | — | 0.99× | ||
| Q1 25 | -4.36× | 0.35× | ||
| Q4 24 | — | 20.38× | ||
| Q3 24 | — | 0.96× | ||
| Q2 24 | — | 3.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LFST
暂无分部数据
SCL
| Surfactants | $453.7M | 75% |
| Polymers | $130.0M | 22% |
| Specialty Products | $20.8M | 3% |
